MT
Mukesh Thapak Kumar
About Mukesh Thapak Kumar
Data last updated:
Mukesh Thapak Kumar has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Munic Life Sciences Private Limited and Mespa Health Care Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Mespa Health Care Private Limited at ₹1.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Nov 2017 | 2017 | ₹1.38 Cr (FY 2025) | Active | |
| Director | 24 Jun 2022 | 2022 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukesh Thapak Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukesh Thapak Kumar
Mukesh Thapak Kumar has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Munic Life Sciences Private Limited and Mespa Health Care Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Mespa Health Care Private Limited at ₹1.38 Cr (FY 2025).
Mukesh Thapak Kumar is associated with 2 companies as Director, including Mespa Health Care Private Limited (₹1.38 Cr), Munic Life Sciences Private Limited.
Mukesh Thapak Kumar has expertise in General Business, Healthcare.
Mukesh Thapak Kumar has 8 years in corporate governance.
By reported revenue, the largest current company of Mukesh Thapak Kumar is Mespa Health Care Private Limited, with revenue of ₹1.38 Cr (FY 2025).
Mukesh Thapak Kumar currently holds positions at 2 companies: Mespa Health Care Private Limited (₹1.38 Cr), Munic Life Sciences Private Limited.